By Professor David Lawson Morris

Journal articles

Steinke K; King J; Glenn D; Morris DL, 2004, 'Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC) - One-year follow-up', Radiologe, 44, pp. 687 - 692

Pourgholami MH; Morris DL, 2004, '1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies', Journal of Steroid Biochemistry and Molecular Biology, 89-90, pp. 513 - 518

D Souza RJ; Yeo J; King J; Morris DL, 2004, 'A comparison of morbidity and mortality rates and long term survival following liver resection of cryotherapy for hepatocellular carcinoma', Cryosurgery, January, pp. 7 - 14

Haghighi K; Woon WW; Akhter J; Marr PJ; Bolton E; Riordan S; Morris DL, 2004, 'A new source of Hepatocytes for transplantation', Transplantation Proceedings, 36, pp. 2466 - 2468

Haghighi K; Woon WW; Akhter J; Marr PJ; Bolton E; Riordan SM; Morris DL, 2004, 'A new source of hepatocytes for transplantation', Transplantation Proceedings, 36, pp. 2466 - 2468

Sathasivam S; Ritchie A; Brooks AJ; Morris DL, 2004, 'Acute pancreatitis following liver resection: Report of three fatal cases and a review of the literature.', Australian and New Zealand Journal of Surgery, 74, pp. 643 - 645

Soon PSH; Vallentine J; Palmer AW; Magarey CJ; Schwartz P; Morris DL, 2004, 'Echogenicity of breast cancer: is it of prognostic value?', Breast, 13, pp. 194 - 199

Gananadha S; Morris DL, 2004, 'Novel in-line multielectrode radiofrequency ablation considerably reduces blood loss during liver resection in an animal model', Australian and New Zealand Journal of Surgery, 74, pp. 482 - 485

Steinke K; Glenn DW; King J; Clark W; Zhao J; Clingan PR; Morris DL, 2004, 'Percutaneous imaging - Guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up', Annals of Surgical Oncology, 11, pp. 207 - 212

Steinke K; King J; Glenn DW; Morris DL, 2004, 'Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: Tips from preliminary experience', American Journal of Roentgenology, 183, pp. 605 - 611

King J; Glenn DW; Clark W; Zhao J; Clingan PR; Morris DL, 2004, 'Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer', British Journal of Surgery, 91, pp. 217 - 223

Steinke K; Sewell PE; Dupuy D; Lencioni R; Glenn DW; King J; Morris DL, 2004, 'Pulmonary radiofrequency ablation - An international study survey', Anticancer Research, 24, pp. 339 - 344

Steinke K; King J; Glenn DW; Morris DL, 2004, 'Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC) - one-year follow-up', Der Radiologe, 44, pp. 687 - 692

Morris DL; Glenn DR; King JE; Lencioni R; Regge D; Suh R; Gilliams A; Helmberger T; Dereskewitz C, 2004, 'Radiofrequency ablation (RFA) of pulmonary colorectal metastases', Journal of Clinical Oncology, 22, pp. 302S - 302S

Pourgholami MH; Lu Y; Wang L; Stephens RW; Morris DL, 2004, 'Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in lipiodol', Cancer Letters, 207, pp. 37 - 47

Gananadha S; Wulf S; Morris DL, 2004, 'Safety and efficacy of radiofrequency ablation of brain: a potentially minimally invasive treatment for brain tumours', Minimally Invasive Neurosurgery, 47, pp. 325 - 328

Gananadha S; Morris DL, 2004, 'Saline infusion markedly reduces impedance and improves efficacy of pulmonary radiofrequency ablation', Cardiovascular and Interventional Radiology, 27, pp. 361 - 365

Clavien PA; Dahm F; Selzner N; Selzner M, 2003, 'Hepatic artery chemotherapy and colorectal liver mestastases.', Lancet, 361, pp. 1742 - 1743, http://dx.doi.org/10.1016/s0140-6736(03)13341-7

Calvo E; Sureda M, 2003, 'Hepatic artery chemotherapy and colorectal liver mestastases.', Lancet, 361, pp. 1743, http://dx.doi.org/10.1016/s0140-6736(03)13342-9

Clavien PA; Dahm F; Selzner N; Selzner M, 2003, 'Hepatic artery chemotherapy and colorectal liver mestastases.', Lancet, 361, http://dx.doi.org/10.1016/S0140-6736(03)13341-7

Morris DL; Steinke K, 2003, 'Portal vein thrombosis after radiofrequency ablation for recurrent hepatocellular carcinoma: Invited commentary', Asian Journal of Surgery, 26, pp. 54, http://dx.doi.org/10.1016/S1015-9584(09)60219-0

Caputo A; Pourgholami MH; Akhter J; Morris DL, 2003, '1,25-Dihydroxyvitamin D3 induced cell cycle arrest in the human primary liver cancer cell line HepG2', Hepatology Research, 26, pp. 34 - 39

Gruenberger T; Bowrey P; L Morris D, 2003, '24', Journal of Gastrointestinal Surgery, 7, pp. 265 - 265, http://dx.doi.org/10.1016/s1091-255x(02)00225-1

S Zuckerman R; Yan DB; L Morris D, 2003, '6', Journal of Gastrointestinal Surgery, 7, pp. 260 - 260, http://dx.doi.org/10.1016/s1091-255x(02)00207-x

Steinke K; Gananadha S; King J; Zhao J; Morris DL, 2003, 'Dispersive pad site burns with modern radiofrequency ablation equipment', Surgical Laparoscopy Endoscopy and Percutaneous Techniques, 13, pp. 366 - 371

Louie-Johnsun MW; Hewitt PM; Perera S; Morris DL, 2003, 'Fibrolamellar hepatocellular carcinoma in pregnancy', HPB, 5, pp. 191 - 193

Yan DB; Clingan PR; Morris DL, 2003, 'Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma', Cancer, 98, pp. 320 - 330

Kozman DR; Thornton MJ; Lubowski DZ; Morris DL; King DW, 2003, 'HEPATIC METASTASIS FROM COLORECTAL CANCER: AN ANALYSIS OF MORBIDITY AND MORTALITY OF METACHRONOUS AND SYNCHRONOUS TREATMENT', American Journal of Gastroenterology, 98, pp. S99 - S99, http://dx.doi.org/10.1111/j.1572-0241.2003.08027.x

Kariappa S; Links MJ; Morris DL, 2003, 'Non-Surgical treatment options in hepatocellular carcinoma', Cancer Reviews Asia - Pacific, 1, pp. 245 - 279

Steinke K; Glenn DW; King J; Morris DL, 2003, 'Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions', British Journal of Radiology, 76, pp. 742 - 745

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Percutaneous radiofrequency of lung tumors: Difficulty withdrawing the hooks resulting in a split needle', Cardiovascular and Interventional Radiology, 26, pp. 583 - 585

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed?', Interactive Cardiovascular and Thoracic Surgery, 2, pp. 462 - 465

Steinke K; King J; Glenn DW; Morris DL, 2003, 'Radiologic appearance and complications of percutaneous computed tomography- Guided radiofrequency-Ablated pulmonary metastases from colorectal carcinoma', Journal of Computer Assisted Tomography, 27, pp. 750 - 757

King J; Zhao J; Clingan PR; Morris DL, 2003, 'Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, marimastat in patients with inoperable colorectal hepatic metastases: Significant survival advantage in patients with musculoskeletal side-effec', Anticancer Research, 23, pp. 639 - 646

Steinke K; Arnold C; Wulf S; Morris DL, 2003, 'Safety of radiofrequency ablation of myocardium and lung adjacent to the heart: An animal study', Journal of Surgical Research, 114, pp. 140 - 145

May LA; Huang Q; Morris D; Danis V; Manolios N, 2002, 'Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus', LUPUS, 11, pp. 114 - 118, http://dx.doi.org/10.1191/0961203302lu151oa

King J; Caplehorn JR; Seifert J; Preketes AO; Clingan PR; Morris DL, 2002, 'A Randomised Placebo Control Double-blind trial of Ranitidine in Patients with Colorectal Hepatic Metastases: Survival Advantage in Patients with Poor Cell Mediated Immunity', Gastrointestinal Oncology, 4, pp. 39 - 44

Hewitt PM; Armstrong N; Bowrey P; Cherian M; Morris DL, 2002, 'Cimetidine prevents suppression of delayed hypersensitivity in an animal model of hemorrhagic shock', Injury - International Journal of the Care of the Injured, 33, pp. 673 - 678

Gruenberger T; King J; Chung TT; Clingan PR; Morris DL, 2002, 'Echogenicity of Liver Metastases from Colorectal Carcinoma Is an Independent prognostic Factor in Patients Treated with Regional Chemotherapy', Cancer, 94, pp. 1753 - 1759

Talbot ML; Clark JR; Clingan PR; Morris DL, 2002, 'Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain', HPB, 4, pp. 29 - 34

Morris DL; Jourdan JL; Finlay I; Gruenberger T; The MP; Pourgholami MH, 2002, 'Hepatic intra-arterial injection of 1,25-dihydroxyvitamin D3 in lipiodol: Pilot study in patients with hepatocellular cacinoma', International Journal of Oncology, 21, pp. 901 - 906

Seifert JK; France MP; Zhao J; Bolton E; Finlay I; Junginer T; Morris DL, 2002, 'Large volume hepatic freezing: Association with significant release of the cytokines interleukin-6 and tumor necrosis factor alpha in a rat model', World Journal of Surgery, 26, pp. 1333 - 1341

Gananadha S; Morris DL, 2002, 'Radiofrequency Ablation of Liver Malignancies', Gastrointestinal Oncology, 4, pp. 49 - 58

Gruenberger T; Morris DL, 2002, 'Stage treatment of bilobar hepatic metastases from colorectal cancer', European Journal of Surgery, 168, pp. 516 - 518

Morris DL, 2002, 'Surgery for liver metastases: How many?', Australian and New Zealand Journal of Surgery, 72, pp. 2 - 2

Terrett D; Lu Y; Bowrey P; Bolton EJ; Morris DL, 2001, 'Cimetidine increases lymphocyte infiltration alters cytokine gene expression in a murine colorectal cancer model', GI Cancer, 3, pp. 407 - 418

Morris DL; Jourdan JL; Pourgholami MH, 2001, 'Pilot study of albendazole in patients with advanced malignancy: Effect on serum tumor markers/high incidence of neutropenia', Oncology, 61, pp. 42 - 46, http://dx.doi.org/10.1159/000055351

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1α,25-dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2', ANZ Journal of Surgery, 71, pp. 414 - 417, http://dx.doi.org/10.1046/j.1440-1622.2001.02147.x

Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL, 2001, '1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2', Australian and New Zealand Journal of Surgery, pp. 414 - 417

Finlay I; Stewart GJ; Akhter J; Morris DL, 2001, 'A phase one study of the hepatic arterial administration of 1,25-dihydroxyvitamin D3 for liver cancers', Journal of Gastroenterology and Hepatology, 16, pp. 333 - 337

Back to profile page